Invesco Pharmaceuticals ETF (NYSEARCA:PJP) Short Interest Update

Invesco Pharmaceuticals ETF (NYSEARCA:PJP) was the recipient of a large decline in short interest in March. As of March 13th, there was short interest totaling 1,015 shares, a decline of 81.1% from the February 26th total of 5,366 shares. Based on an average daily trading volume, of 13,272 shares, the days-to-cover ratio is currently 0.1 days. Approximately 0.0% of the company’s stock are short sold.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. IFP Advisors Inc grew its stake in Invesco Pharmaceuticals ETF by 31.3% in the fourth quarter. IFP Advisors Inc now owns 440 shares of the company’s stock valued at $46,000 after purchasing an additional 105 shares in the last quarter. Flagship Harbor Advisors LLC boosted its holdings in shares of Invesco Pharmaceuticals ETF by 1.8% in the 4th quarter. Flagship Harbor Advisors LLC now owns 6,049 shares of the company’s stock valued at $632,000 after buying an additional 105 shares during the last quarter. J.W. Cole Advisors Inc. boosted its holdings in shares of Invesco Pharmaceuticals ETF by 4.7% in the 4th quarter. J.W. Cole Advisors Inc. now owns 2,910 shares of the company’s stock valued at $304,000 after buying an additional 131 shares during the last quarter. Northwestern Mutual Wealth Management Co. grew its stake in shares of Invesco Pharmaceuticals ETF by 5.7% in the third quarter. Northwestern Mutual Wealth Management Co. now owns 2,791 shares of the company’s stock valued at $258,000 after buying an additional 150 shares in the last quarter. Finally, Rockefeller Capital Management L.P. grew its stake in shares of Invesco Pharmaceuticals ETF by 20.5% in the fourth quarter. Rockefeller Capital Management L.P. now owns 1,230 shares of the company’s stock valued at $129,000 after buying an additional 209 shares in the last quarter.

Invesco Pharmaceuticals ETF Trading Down 0.3%

Shares of Invesco Pharmaceuticals ETF stock traded down $0.33 during trading hours on Thursday, reaching $101.70. 6,138 shares of the company’s stock were exchanged, compared to its average volume of 41,609. The stock has a market cap of $388.49 million, a P/E ratio of 15.59 and a beta of 0.50. The company has a 50 day moving average of $106.05 and a two-hundred day moving average of $101.90. Invesco Pharmaceuticals ETF has a fifty-two week low of $72.25 and a fifty-two week high of $110.81.

About Invesco Pharmaceuticals ETF

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types.